OR Prescription Drug Monitoring Program v. ACLU

Oregon sought a declaratory judgment that, under state law, the DEA must obtain a court order to enforce investigative subpoenas. The ACLU intervened, arguing that the DEA's use of subpoenas violated their Fourth Amendment rights. The district court reached the merits of the Fourth Amendment claim and found a violation of privacy interests asserted by the ACLU. The Ninth Circuit reversed without reaching the merits of the Fourth Amendment claim, holding that the ACLU lacked Article III standing to seek declaratory and injunctive relief prohibiting the DEA from obtaining prescription records without a warrant supported by probable cause. The panel explained that the Supreme Court recently clarified this independent standing requirement for intervenors in Town of Chester v. Laroe Estates, No. 16-605, slip op. at 6 (U.S. June 5, 2017). The panel also held that the federal administrative subpoena statute, 21 U.S.C. 876, preempted Oregon's statutory court order requirement. View "OR Prescription Drug Monitoring Program v. ACLU" on Justia Law